No Link Between Blood Pressure Drugs and Cancer Found: FDA

|
Staff Writers

Add Your Comments

Federal drug safety experts say they can find no link between cancer and a popular class of blood pressure control medications, which include Benicar, Atacand, Avapro, Cozaar, Diovan, Micardis and Tevetan. 

The FDA launched a drug safety review of the blood pressure control drugs, known as angiotensin receptor blockers (ARBs), in July 2010, after some data suggested the medications may increase the risk of cancer.

Reviewers who looked at all the available data determined that the drugs do not increase the risk of cancer, given the data currently available. The agency’s findings were announced on Thursday in an ARB drug safety communication.

Do You Know about…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION
Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Do You Know About…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION

As part of the safety review, the FDA conducted a trial-level meta-analysis of 31 clinical trials where patients were given an ARB or non-ARB treatment. The trials included about 156,000 patients collectively.

The FDA recommends that patients do not stop taking ARB medication without first consulting a health care professional.

The FDA review was initiated after a study on side effects of Benicar published last year in the medical journal Lancet Oncology found that the use of ARBs was linked to a 1% increase in the risk a number of forms of cancer, including lung, prostate and breast cancer.

Benicar was already under investigation by the FDA due to two recent studies that suggest the drug can cause an increase in the risk of death due to heart problems in patients with type 2 diabetes. FDA officials are concerned that the side effects of Benicar may have played a factor in the cardiovascular deaths of 25 test subjects who participated in the two studies.

Tags: Atacand, Avapro, Benicar, Blood, Breast Cancer, Cozaar, Diabetes, Diovan, Micardis, Tevetan
Image Credit: |

More Benicar Lawsuit Stories

0 Comments

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Proclaim Spinal Cord Stimulator Lawsuit Follows Infection, Battery Migration
A Texas man’s lawsuit claims the electrodes and battery of an Abbott spinal cord stimulator tried to push out of his skin, resulting in a severe infection and the need for surgical removal.
Olympus Scope Infection Lawsuits Over FDA Warnings
Federal warnings and enforcement actions involving Olympus and other reusable medical scopes have raised concerns that design flaws may allow bacteria to remain trapped after cleaning, leading to serious infections and product liability lawsuits.
DraftKings Gambling Addiction Problems Caused by Intentional Algorithm Design Lawsuit
An Illinois man has filed a lawsuit saying DraftKings uses malicious algorithms designed to detect and exploit potential compulsive gambling triggers.